{{Rsnum
|rsid=10083466
|Gene=NRXN3
|Chromosome=14
|position=79518375
|Orientation=plus
|GMAF=0.3972
|Gene_s=NRXN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 4.5 | 38.7 | 56.8
| HCB | 12.6 | 55.6 | 31.9
| JPT | 14.5 | 48.2 | 37.3
| YRI | 73.3 | 26.7 | 0.0
| ASW | 45.6 | 43.9 | 10.5
| CHB | 12.6 | 55.6 | 31.9
| CHD | 17.9 | 51.9 | 30.2
| GIH | 18.8 | 51.5 | 29.7
| LWK | 67.9 | 30.3 | 1.8
| MEX | 3.5 | 33.3 | 63.2
| MKK | 68.4 | 30.3 | 1.3
| TSI | 9.9 | 45.5 | 44.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23245376
|Title=Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}